One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.
Edited and Published by Gordon Pape. Associate Editor: Richard Croft
With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.
Recent Issues
iwb21413 (March 31, 2014)
Value for money… Pipe or perish… Tom Slee picks Altagas… Tom Slee updates Bombardier, Manulife Financial, Intact Financial, Chicago Bridge and Iron… More on PFICs… Gordon Pape’s updates: Saputo Inc., L Brands, Southern Company… Your Questions: U.S. withholding tax, sell or buy, old stock certificates
iwb21412 (March 24, 2014)
Quebec and the markets… Miserable winter made this company happy… Glenn Rogers updates American Airlines, Market Vectors Russia ETFs, Market Vectors Rare Earths/Strategic Metals ETFs… Gordon Pape updates Franklin Bissett Canadian Equity Fund, Leith Wheeler Canadian Equity Fund, Mawer Tax-Effective Balanced Fund, Mawer U.S. Equity Fund, PH&N Short Term Bond and Mortgage Fund, PH&N Total Return Bond Fund… A warning for U.S. citizens… Members’ corner
iwb21411 (March 17, 2014)
Russia, Ukraine, and political crises… Gavin Graham’s updates: iShares MSCI Emerging Markets ETF, Home Capital Group, Linamar Corp… Building an RESP… More updates: Equitable Group, Black Creek International Equity Fund, BMG BullionFund, Fidelity Canadian Balanced Fund, Mawer Balanced Fund
iwb21410 (March 10, 2014)
Why I bought Google… Conservative portfolio update… With current valuations, selectivity is the key… Ryan Irvine updates McCoy Corp., Monument Mining, Glentel, Parex Resouces… Gordon Pape’s updates: Gibson Energy, Trinidad Drilling, Shaw Communications… Your Questions: Capital losses… Members’ Corner: Tax software
Recent Updates
Pfizer Inc. (NYSE: PFE)
Pfizer is a leading international pharmaceutical company that can trace its history back more than 170 years. Its business units include Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines, and Internal Medicine. Pfizer was the first company (along with partner BioNTech) to have a Covid vaccine approved for general use. It has proven to be highly effective with minimal side effects. The company has also developed a drug to treat the virus.
Hold
Winpak Ltd. (TSX: WPK, OTC: WIPKF)
Winpak produces goods that are mainly used in the food and beverage and healthcare industries. Its modified atmosphere packaging is used to extend the shelf life of perishable products such as meat, poultry, and cheese as well as healthcare products. The majority of its sales are in North America.
Buy
Cameco Corp. (TSX: CCO, NYSE: CCJ)
Cameco is one of the world’s largest uranium producers, with mines at McArthur River and Cigar Lake in Saskatchewan and refineries in Ontario. As governments and investors have become more favourably inclined towards non-carbon emitting sources of baseload power such as nuclear in recent years, Cameco’s fortunes and its share price have revived.
Sell half
CGI Group (TSX: GIB.A, NYSE: GIB)
CGI is the fifth largest independent information technology and business process services firm in the world. The company, founded in 1976, delivers an end-to-end portfolio of capabilities, from IT and business consulting to systems integration, outsourcing services, and intellectual property solutions. It employs about 93,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region.
Hold
Bank of Nova Scotia (TSX, NYSE: BNS)
Scotiabank is the most internationally diversified of the major Canadian banks, with over 30% of its assets coming from its overseas operations, primarily what the bank describes as the three Pacific Alliance countries of Mexico, Peru, and Chile. It sold its subscale operations in Colombia, Panama, and Costa Rica to bank Davivienda in the first quarter in exchange for a 20% stake in Davivienda, taking a $1.4 billion impairment charge on the sale. Scotiabank has strengths in mortgage and corporate lending and wealth management and is usually the lowest cost operator amongst the major banks.